2113. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has analysed prescribing substitution patterns for salbutamol nebules during supply shortages, including increased dispensing of inhalers or alternative bronchodilators. [20303/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
27,342 questions match, newest first.
2114. Deputy Ken O'Flynn asked the Minister for Health whether a national governance framework exists within her Department or the Health Service Executive for the monitoring and management of shortages of essential medicines; the statutory or policy basis for that framework; the units responsible for maintaining national oversight; and if she will make a statement on the matter. [20305/26]
2115. Deputy Ken O'Flynn asked the Minister for Health whether the Department receives regular national reports or aggregated data from the Health Products Regulatory Authority or the Health Service Executive relating to shortages of medicines in the State; the frequency of such reporting; and whether the Department maintains a national register or monitoring system for medicines supply disruptions. [20306/26]
2116. Deputy Ken O'Flynn asked the Minister for Health whether a formal risk-assessment or prioritisation system exists within the Department or the Health Service Executive for identifying medicines considered clinically critical, including respiratory medicines such as salbutamol nebules, where supply disruptions may pose patient safety risks; and if she will outline the governance arrangements for managing such ri…
2117. Deputy Ken O'Flynn asked the Minister for Health whether her Department maintains a national strategy or policy framework for the prevention, monitoring, and management of shortages of essential medicines in the State; when such a strategy was last reviewed or updated; whether it includes defined governance arrangements between her Department, the Health Products Regulatory Authority, and the Health Service Exe…
2118. Deputy Ken O'Flynn asked the Minister for Health whether her Department has issued any written policy guidance, circular, direction or framework to the Health Service Executive or to the National Centre for Pharmacoeconomics regarding the appropriate time horizon to be applied in health technology assessments used to inform pricing and reimbursement decisions for medicines; if such guidance exists, to provide t…
2119. Deputy Ken O'Flynn asked the Minister for Health whether national policy guidance exists governing the methodological standards to be applied in health technology assessments used to support decisions under the Health (Pricing and Supply of Medical Goods) Act 2013, including assumptions relating to modelling time horizons, discount rates and long-term cost-effectiveness analysis; and if she will make a statemen…
2120. Deputy Ken O'Flynn asked the Minister for Health whether her Department has issued guidance to ensure that health technology assessments of medicines intended to prevent or reduce the long-term incidence of chronic diseases, including type 2 diabetes or cardiovascular disease, appropriately account for long-term health outcomes and downstream health system savings; and if she will make a statement on the matter…
2121. Deputy Ken O'Flynn asked the Minister for Health what oversight role her Department exercises in relation to the methodological frameworks used by the National Centre for Pharmacoeconomics when conducting health technology assessments that inform reimbursement decisions by the Health Service Executive; and if she will make a statement on the matter. [20313/26]
2122. Deputy Ken O'Flynn asked the Minister for Health whether her Department has reviewed whether the health technology assessment methodology applied in Ireland is aligned with that used by comparable agencies internationally, including NICE in the United Kingdom, CADTH in Canada, or PBAC in Australia, particularly regarding the time horizons applied in cost-effectiveness modelling for preventive medicines; and if …
2123. Deputy Ken O'Flynn asked the Minister for Health whether her Department has undertaken any review of whether the methodological assumptions applied in health technology assessments used in Ireland may disadvantage medicines intended to prevent long-term chronic illness by applying short-term modelling horizons; and if she will make a statement on the matter. [20315/26]
2124. Deputy Ken O'Flynn asked the Minister for Health whether her Department intends to establish a national policy framework or guidance governing the methodological standards used in health technology assessments for medicines seeking reimbursement by the Health Service Executive, including standards relating to modelling time horizons for chronic disease prevention therapies; and if she will make a statement on t…
2125. Deputy Aidan Farrelly asked the Minister for Health the amount paid in legal costs to each of the top ten legal firms representing plaintiffs in medical negligence cases in 2024 and 2025; the number of cases payments relate to, in tabular form; and if she will make a statement on the matter. [20318/26]
2126. Deputy Aidan Farrelly asked the Minister for Health the amount paid out in legal costs to each of the top ten named legal firms representing the agency in medical negligence cases in 2024 and 2025; the number of cases payments relate to, in tabular form; and if she will make a statement on the matter. [20319/26]
2127. Deputy Ken O'Flynn asked the Minister for Health whether her Department has issued any written policy guidance or governance framework defining what constitutes an unacceptable response time for life-threatening emergency ambulance calls, including clinical status 1 purple or red calls; and if she will make a statement on the matter. [20321/26]
2128. Deputy Ken O'Flynn asked the Minister for Health whether her Department has formally approved or endorsed the current key performance indicator framework used by the National Ambulance Service in relation to emergency response times; the date on which that framework was last reviewed by her Department; and whether consideration has been given to introducing a maximum response time threshold for life-threatening…
2129. Deputy Ken O'Flynn asked the Minister for Health whether the absence of a defined maximum response time threshold for life-threatening emergency ambulance calls has been assessed by her Department as a governance or patient safety risk; and whether any such assessment has been recorded within the Department’s risk management framework. [20323/26]
2130. Deputy Ken O'Flynn asked the Minister for Health whether her Department has required the Health Service Executive to provide any analysis of emergency ambulance response times exceeding 60 minutes for clinical status 1 purple or red calls; whether such analysis has been reviewed at Departmental level; and if she will make a statement on the matter. [20324/26]
2131. Deputy Ken O'Flynn asked the Minister for Health whether her Department has considered whether delays exceeding 60 minutes in response to life-threatening emergency calls should automatically trigger review under the HSE Incident Management Framework; and if so, the outcome of that consideration. [20325/26]
2132. Deputy Ken O'Flynn asked the Minister for Health whether the Department of Health receives any routine reporting from the Health Service Executive regarding extreme outlier emergency ambulance response times, including delays exceeding 60 minutes for life-threatening emergencies; the format in which such information is reported; and whether this information forms part of Departmental oversight of patient safety…
2133. Deputy Ken O'Flynn asked the Minister for Health whether the Department of Health Enterprise Risk Management Framework currently identifies prolonged emergency ambulance response times as a strategic or operational risk; and if so, the risk rating assigned and the mitigation measures identified. [20327/26]
2134. Deputy Ken O'Flynn asked the Minister for Health whether her Department has undertaken or commissioned any review since 2020 examining the relationship between prolonged ambulance response times and patient outcomes in Ireland; and if so, the title and date of any such review. [20328/26]
2135. Deputy Ken O'Flynn asked the Minister for Health whether her Department has considered the introduction of national reporting requirements for extreme ambulance response delays for life-threatening emergencies in order to strengthen transparency and patient safety oversight. [20329/26]
2136. Deputy Ken O'Flynn asked the Minister for Health whether the governance arrangements between her Department and the Health Service Executive require the HSE to notify the Department where systemic patterns of prolonged ambulance response delays emerge; and if so, the mechanism through which such notification occurs. [20330/26]
2137. Deputy Séamus McGrath asked the Minister for Health to clarify the position with respect to healthcare workers suffering from long-Covid and Critical Illness Protocols. [20331/26]